Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Metastatic Colorectal Cancer Database
- Status
- UNKNOWN
- Phase
- N/A
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR
- Status
- UNKNOWN
- Phase
- PHASE2
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
- Status
- COMPLETED
- Phase
- N/A
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2